Immunovant, Inc.
IMVT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001764013
In the last 90 days, Immunovant, Inc. insiders filed 0 open-market purchases and 10 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.25B in total; Greenlight Capital is the only superinvestor holding it.
Q2 2026 vs. Q1 2026
How the institutions holding Immunovant, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 216 | 4 | 226 | +14 |
| Shares | 110.6M | 72.4K | 110.4M | −172.0K (−0.2%) |
| Value | $2.75B | $1.80M | $4.25B | +$1.51B (+54.8%) |
4 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (38)
Institutions that held Immunovant, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
Sold out (24)
Institutions that held Immunovant, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Candriam Luxembourg S.C.A. | 680,372 | $16.9M |
| Great Point Partners LLC | 545,625 | $13.6M |
| Trails Edge Capital Partners, LP | 414,054 | $10.3M |
| Adage Capital Partners GP, L.L.C. | 413,000 | $10.3M |
| Prosight Management, LP | 175,825 | $4.37M |
| Blackstone Group Inc. | 107,297 | $2.67M |
| Jane Street Group, LLC | 84,312 | $2.09M |
| ArrowMark Colorado Holdings LLC | 70,000 | $1.74M |
| Schonfeld Strategic Advisors LLC | 33,553 | $833.5K |
| Ellsworth Advisors, LLC | 32,280 | $801.8K |
| LMR Partners LLP | 26,045 | $647.0K |
| Inceptionr LLC | 24,272 | $602.9K |
| ExodusPoint Capital Management, LP | 21,941 | $545.0K |
| Group One Trading, L.P. | 20,586 | $511.4K |
| Hudson Bay Capital Management LP | 19,230 | $477.7K |
| Nomura Holdings Inc | 16,011 | $397.7K |
| Marex Group plc | 16,000 | $397.4K |
| Oxford Asset Management LLP | 12,456 | $309.4K |
| Westfield Capital Management Co LP | 8,581 | $213.2K |
| Quadrant Capital Group LLC | 212 | $5.27K |
| MAI Capital Management | 20 | $497 |
| First Command Advisory Services, Inc. | 10 | $248 |
| Advisory Services Network, LLC | 9 | $224 |
| Twin Peaks Wealth Advisors, LLC | 3 | $75 |
Not filed for Q2 2026 yet (4)
Institutions that held Immunovant, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Deeter Investments LLP | 37,000 | $919.1K |
| Janus Henderson Group PLC | 33,731 | $838.2K |
| CWM, LLC | 1,427 | $35.4K |
| Red Tortoise LLC | 242 | $6.01K |